Perrigo Company (NYSE:PRGO) has earned an average recommendation of “Hold” from the eighteen research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $92.13.

A number of equities research analysts have recently issued reports on PRGO shares. Cantor Fitzgerald reissued a “buy” rating on shares of Perrigo in a research report on Monday, August 21st. Oppenheimer started coverage on shares of Perrigo in a research report on Thursday, September 7th. They set an “outperform” rating and a $88.00 price objective for the company. CIBC started coverage on shares of Perrigo in a research report on Thursday, September 7th. They set an “outperform” rating and a $88.00 price objective for the company. BidaskClub raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research report on Saturday, September 9th. Finally, Canaccord Genuity reissued a “buy” rating and set a $100.00 price objective (up previously from $88.00) on shares of Perrigo in a research report on Wednesday, September 13th.

Shares of Perrigo (PRGO) traded up $0.10 during mid-day trading on Thursday, hitting $86.02. 1,106,400 shares of the stock were exchanged, compared to its average volume of 1,683,894. Perrigo has a 12-month low of $63.68 and a 12-month high of $91.73. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.24 and a current ratio of 1.72. The company has a market cap of $12,120.00, a P/E ratio of 17.53, a price-to-earnings-growth ratio of 1.83 and a beta of 0.64.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, November 9th. The company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.28. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. The firm had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the firm posted $1.65 EPS. The company’s revenue for the quarter was down 2.0% compared to the same quarter last year. sell-side analysts expect that Perrigo will post 4.88 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 19th. Shareholders of record on Friday, December 1st will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.74%. The ex-dividend date is Thursday, November 30th. Perrigo’s payout ratio is currently -6.99%.

In other Perrigo news, EVP John Wesolowski sold 450 shares of the business’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $83.09, for a total value of $37,390.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders sold 1,051 shares of company stock worth $89,810. Corporate insiders own 6.90% of the company’s stock.

A number of hedge funds have recently made changes to their positions in PRGO. Franklin Resources Inc. lifted its stake in Perrigo by 117.7% in the 2nd quarter. Franklin Resources Inc. now owns 8,109,742 shares of the company’s stock worth $612,448,000 after purchasing an additional 4,383,903 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Perrigo by 3,286.6% during the 3rd quarter. Victory Capital Management Inc. now owns 1,074,770 shares of the company’s stock valued at $90,979,000 after buying an additional 1,043,034 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Perrigo by 50.9% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,846,993 shares of the company’s stock valued at $139,485,000 after buying an additional 623,370 shares in the last quarter. Greenlight Capital Inc. raised its position in shares of Perrigo by 14.8% during the 3rd quarter. Greenlight Capital Inc. now owns 2,901,032 shares of the company’s stock valued at $245,572,000 after buying an additional 374,032 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Perrigo during the 2nd quarter valued at about $27,377,000. Institutional investors and hedge funds own 85.53% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Perrigo Company (PRGO) Given Consensus Rating of “Hold” by Analysts” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/14/perrigo-company-prgo-given-consensus-rating-of-hold-by-analysts.html.

About Perrigo

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.